open access
Online first
Short communication
Published online: 2023-02-05
Get Citation
A favorable alliance between repetitive use of levosimendan and advanced heart failure: Polish two-centered inpatient perspective in need of validation
Marcin Książczyk1, Marcin Gruchała2, Iwona Stopczyńska2, Małgorzata Lelonek1
Affiliations- Department of Noninvasive Cardiology, Medical University of Lodz, Łódź, Poland
- 1st Department of Cardiology, Medical University of Gdansk, Gdańsk, Poland
open access
Online first
Short communication
Published online: 2023-02-05
Abstract
Not available
Abstract
Not available
Get Citation
Supp./Additional Files (1)
About this articleTitle
A favorable alliance between repetitive use of levosimendan and advanced heart failure: Polish two-centered inpatient perspective in need of validation
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Published online
2023-02-05
Page views
61
Article views/downloads
41
DOI
10.33963/KP.a2023.0034
Pubmed
Authors
Marcin Książczyk
Marcin Gruchała
Iwona Stopczyńska
Małgorzata Lelonek
References (15)- Crespo-Leiro MG, Metra M, Lund LH, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018; 20(11): 1505–1535.
- McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42: 3599–3726.
- Lelonek M, Stopczyńska I, Korościk E, et al. Multicenter experiences with levosimendan therapy and its safety in patients with decompensated advanced heart failure. Adv Clin Exp Med. 2020; 29(11): 1305–1312.
- Ahmad T, Miller PE, McCullough M, et al. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. Eur J Heart Fail. 2019; 21(9): 1064–1078.
- Tycińska A, Gierlotka M, Bugajski J, et al. Levosimendan in the treatment of patients with acute cardiac conditions: an expert opinion of the Association of Intensive Cardiac Care of the Polish Cardiac Society. Kardiol Pol. 2020; 78(7-8): 825–834.
- Packer M, Colucci W, Fisher L, et al. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013; 1(2): 103–111.
- Follath F, Cleland JGF, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002; 360(9328): 196–202.
- Levy B, Buzon J, Kimmoun A. Inotropes and vasopressors use in cardiogenic shock: when, which and how much? Curr Opin Crit Care. 2019; 25(4): 384–390.
- Belletti A, Castro ML, Silvetti S, et al. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. Br J Anaesth. 2015; 115(5): 656–675.
- Delaney A, Bradford C, McCaffrey J, et al. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials. Int J Cardiol. 2010; 138(3): 281–289.
- Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA. 2007; 297(17): 1883–1891.
- Comín-Colet J, Manito N, Segovia-Cubero J, et al. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial. Eur J Heart Fail. 2018; 20(7): 1128–1136.
- García-González MJ, de Mora-Martín M, López-Fernández S, et al. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study. Cardiovasc Drugs Ther. 2013; 27(6): 573–579.
- Altenberger J, Parissis JT, Costard-Jaeckle A, et al. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial. Eur J Heart Fail. 2014; 16(8): 898–906.
- Tycińska A, Gierlotka M, Bartuś S, et al. Repetitive use of LEvosimendan in Ambulatory Heart Failure patients (LEIA-HF) - The rationale and study design. Adv Med Sci. 2022; 67(1): 18–22.
